Cerebral angiography is a medical imaging technique used to visually examine the arteries in the brain and neck. It helps diagnose various conditions like aneurysms, arterial blockages or narrowings, tumors, vascular infections, and arteriovenous malformations. Cerebral angiography can help identify abnormalities in the arteries, detect areas of narrowed arteries which may increase the risk of stroke, locate blood clots or aneurysms, and provide information needed for surgery, such as clipping or repairing an aneurysm. The global cerebral angiography market is estimated to be valued at US$ 17.24 Bn in 2024 and is expected to exhibit a CAGR of 8.8% over the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the cerebral angiography market are Kyowa Hakko Bio Co., Ltd., Shandong Jincheng Biological Pharmaceutical Co., Ltd., KOHJIN Life Sciences Co., Ltd., Shenzhen GSH Bio-Technology Co, Ltd, Kaiping Genuine Biochemical Pharmaceutical Co., Ltd., Nissor Pharmaceuticals Ltd., and Jarrow Formulas, Inc.
The key opportunities in the Global Cerebral Angiography Market Size include increasing prevalence of cerebrovascular diseases, growing aging population, and technological advancements in imaging modalities. Technological advancements have improved the image quality and reduced the invasiveness, time, and radiation exposure of procedures. Flat panel detector angiography systems, subtraction techniques, navigational tools, and 3D reconstruction capabilities have enhanced angiography capabilities.
Market Drivers
The rising geriatric population is a major driver of the cerebral angiography market. The risk of cerebrovascular diseases such as stroke increases with age. According to the WHO, the number of people aged 60 years and older is expected to reach 2 billion by 2050. The elderly are more susceptible to developing conditions like aneurysms, arterial stenosis, and vascular malformations which require cerebral angiography for diagnosis and treatment planning. Therefore, the growing senior population globally will drive the demand for cerebral angiography procedures in the coming years.
Current Challenges in Cerebral Angiography Market
Cerebral Angiography procedures require extensive experience and expertise to perform properly. Lack of trained professionals remains a key challenge for the growth of the cerebral angiography market. Errors during cerebral angiography procedures can lead to severe complications for patients like neurological deficits and major hemorrhages. High cost of cerebral angiography equipment and procedures is another major challenge restricting market growth. Cerebral angiography procedures involve use of X-ray equipment and complex imaging software that carries substantial equipment and maintenance costs. Insurance coverage for cerebral angiography procedures is limited in many developing countries thus limiting its adoption.
SWOT Analysis
Strength: Cerebral angiography offers precise images of blood vessels supplying the brain allowing accurate diagnosis of conditions. Real-time data and high resolution images help doctors take quick therapeutic decisions.
Weakness: Cerebral angiography involves exposure to radiation which can increase long term health risks for patients. It is an invasive procedure carrying risks of infections, bleeding and other complications. Opportunity: Growing geriatric population prone to cerebrovascular diseases is expanding demand for accurate diagnostic techniques. Technological advancements are making equipment more portable and procedures less complex. Threats: High development costs of new technologies pose financial challenges. Alternative non-invasive imaging modalities like CT angiography and MRI angiography are competing technologies.
Geographical Regions
North America dominated the global cerebral angiography market in terms of value in historical period due to developed healthcare infrastructure, rising neurological disorders and availability of advanced treatments. The United States accounted for the major share due to large consumer base and high affordability for expensive cerebral angiography procedures. Europe is second largest region driven by increasing government funding for healthcare and growing occurrence of neurological diseases. Asia Pacific is the fastest growing region supported by expanding medical tourism industry, rising healthcare spending and growing awareness. Countries like China, India and Japan are emerging as major cerebral angiography markets.
